newsfilter
← Latest News
Business Wire·

Organon Cancels First Quarter Earnings Call

Organon (NYSE:OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has canceled its first quarter 2026 earnings conference call